Cerca
Items 21-30 di 32
Influenza dei processi tecnologici sul contenuto di composti bioattivi, bioaccessibilità e attività antiossidante di peperoncini (Capsicum)
(2013-11-28)
Il peperoncino (Capsicum) è da tempo riconosciuto come un’eccellente fonte di composti fitochimici bioattivi quali i carotenoidi, i polifenoli e i capsaicinoidi, noti per esercitare vari effetti biologici positivi e di ...
Modelli sperimentali cellulari e molecolari per la valutazione della tossicità di xenobiotici
(2013-12-02)
The aim of my thesis was to find two different experimental models to study cellular and
molecular xenobiotics toxicity. In the first part of the present work we studied the interaction
between two different plasma ...
Study of autophagic and epigenetic mechanisms in experimental models of inflammatory and neuropathic pain for the identification of new pharmacological targets
(2013-11-28)
Pain is defined by IASP as “an unpleasant sensory and emotional experience
associated with actual or potential tissue damage, or described in terms of such
damage” (IASP, 2011). While physiological pain is like a warning ...
<<The>> estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness
(2013-12-02)
The role of the Forkhead box class O (FoxO)3a transcription factor in breast
cancer migration and invasion is controversial. Here we show that FoxO3a
overexpression decreases motility, invasiveness, and anchorage-indep ...
Caratterizzazione pre-clinica di una nuova strategia terapeutica per l'ischemia cerebrale identificata mediante drug repurposing di un antibiotico macrolide
(2013-11-30)
Cerebral ischemia is one of the most common causes of disability and mortality worldwide and the only pharmacological treatment currently available is thrombolysis. The understanding of the mechanisms underlying ischemic ...
In vitro mechanism for downregulation of erα expression by epigallocatechim gallate in ER+/PR+ human breast cancer cells
(2013-11-26)
La prolungata esposizione agli estrogeni rappresenta un fattore di rischio per lo
sviluppo e la progressione del carcinoma mammario, pertanto la terapia antiestrogenica
è considerata l’approccio terapeutico di elezione ...